Figure 1 demonstrates that diminished Se levels and decreased thioredoxin reductase 1 (TXNRD1) expression compromise antioxidant defense in the thyroid gland
Our results are consistent with the hypothesis that reduced GSH is associated with MDD, which supports the idea that oxidative stress may form part of the mechanism of the underlying MDD (Bhatt et al
Abbreviations CMAP: Compound motor action potential CNS: Central nervous system ECM: Cone-extracellular matrix egr-1 gene : Early growth response-1 gene EMG: Electromyography FAK: Focal adhesion kinase GLP: Good laboratory practice HNE: 4-Hydroxynonenal HPLC: High-pressure liquid chromatography JAK-2: Janus kinase 2 LD1: Lethal dose 1 LTB4: Leukotriene B4 MPO: Myeloperoxidase MPTP: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine MUP: Motor unit potential naB2: Nerve growth factor 1-A binding protein-2 NSAIDs: Non-steroid anti-inflammatory drugs SCI: Spinal cord injury TXB2: Thromboxane B2 References Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, et al
StatPearls notes that high-dose oral B has been shown effective for maintenance, but recommendations are to always use the parenteral route in severe neurological manifestations
Given that the heterogeneity of the reactive astrocyte profile depends on the level and duration of stress exposure, a single therapeutic approach is unlikely to be sufficient for treating multifactorial neurological diseases
Oral supplements face a tough journey through the digestive system, where only 10-50% of the nutrients may be absorbed
